Jaya Julie Joshi

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Jaya Julie Joshi, Heather Coffey, Erik Corcoran et al. · Cancer Research · 2017 · 151 citations

Medicine, Oncology, Pharmacology +15

Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

Manav Korpal, Xiaoling Puyang, Zhenhua J. Wu et al. · Nature Communications · 2017 · 145 citations · Full text

Medicine, Immunology, Oncology +17

Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng et al. · Cancer Discovery · 2018 · 112 citations

Medicine, Oncology, Pharmacology +17

STEP Levels Are Unchanged in Pre-Frontal Cortex and Associative Striatum in Post-Mortem Human Brain Samples from Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder

Thomas A. Lanz, Jaya Julie Joshi, Veronica Reinhart et al. · PLoS ONE · 2015 · 57 citations · Full text

Medicine, Neuroscience, Psychiatry +10

In search of the mechanisms of ketamine’s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis

Susanna Popp, Berthold Behl, Jaya Julie Joshi et al. · F1000Research · 2016 · 33 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15